| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 71,903 | 70,744 | 70,910 | 60,196 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 70,744 | 70,910 | 60,196 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (7,049) | 62,009 | 60,592 | 58,712 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 71,972 | 782 | 714 | 715 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,524 | 7,953 | 9,604 | 769 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,980 | 7,953 | 9,604 | 769 | | Interest Expense | 1,147 | 1,150 | 1,159 | 1,188 | | Income Before Tax | 5,833 | 6,803 | 8,445 | (419) | | Income Tax Expense | 1,585 | 2,519 | 1,662 | 1,953 | | Minority Interest | (36) |
-
|
-
| (35) | | | | Net Income From Continuing Ops | 4,248 | 4,284 | 6,783 | (2,407) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,212 | 4,284 | 6,783 | (2,407) | | Preferred Stock And Other Adjustments | 2 | (9) | 7 |
-
| | | Net Income Applicable To Common Shares | $4,214 | $4,275 | $6,790 | ($2,407) |
|
0.03% Nasdaq 
Income Statement
